T. Petrich

1.0k total citations
21 papers, 740 citations indexed

About

T. Petrich is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, T. Petrich has authored 21 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in T. Petrich's work include Thyroid Cancer Diagnosis and Treatment (13 papers), Medical Imaging Techniques and Applications (9 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). T. Petrich is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (13 papers), Medical Imaging Techniques and Applications (9 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). T. Petrich collaborates with scholars based in Germany, United States and Malaysia. T. Petrich's co-authors include Wolfram H. Knapp, D. Otto, Michael Hofmann, Thomas J. Musholt, A. Börner, Robert J. Marlowe, Lutz S. Freudenberg, Walter Jentzen, E. Pötter and Michael Hofmann and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and Journal of Bone and Mineral Research.

In The Last Decade

T. Petrich

21 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Petrich Germany 15 426 287 195 160 141 21 740
M. Terroir France 14 220 0.5× 121 0.4× 166 0.9× 97 0.6× 86 0.6× 23 424
A. Berdelou France 19 536 1.3× 104 0.4× 350 1.8× 132 0.8× 367 2.6× 35 1.0k
Rixiang Gong China 21 671 1.6× 86 0.3× 458 2.3× 68 0.4× 193 1.4× 55 936
Sheila Lindsay United States 12 296 0.7× 87 0.3× 117 0.6× 36 0.2× 189 1.3× 19 569
Jingqiang Zhu China 17 507 1.2× 93 0.3× 316 1.6× 55 0.3× 143 1.0× 47 740
S. Hescot France 15 233 0.5× 52 0.2× 285 1.5× 107 0.7× 191 1.4× 48 604
Francesca Torresan Italy 14 356 0.8× 44 0.2× 273 1.4× 52 0.3× 94 0.7× 50 578
Anthony Glover Australia 17 522 1.2× 82 0.3× 409 2.1× 53 0.3× 128 0.9× 70 970
Helina Somervell United States 14 360 0.8× 42 0.1× 308 1.6× 82 0.5× 111 0.8× 20 718
Uwe Mäder Germany 20 902 2.1× 176 0.6× 532 2.7× 58 0.4× 155 1.1× 38 1.1k

Countries citing papers authored by T. Petrich

Since Specialization
Citations

This map shows the geographic impact of T. Petrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Petrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Petrich more than expected).

Fields of papers citing papers by T. Petrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Petrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Petrich. The network helps show where T. Petrich may publish in the future.

Co-authorship network of co-authors of T. Petrich

This figure shows the co-authorship network connecting the top 25 collaborators of T. Petrich. A scholar is included among the top collaborators of T. Petrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Petrich. T. Petrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartenstein, Peter, C.L. Maini, Renzo Mazzarotto, et al.. (2013). High-Risk Patients with Differentiated Thyroid Cancer T4 Primary Tumors Achieve Remnant Ablation Equally Well Using rhTSH or Thyroid Hormone Withdrawal. Thyroid. 24(3). 480–487. 23 indexed citations
2.
Krull, David, et al.. (2011). 211At-AntiCD33 in NMRI nu/nu mice. Nuklearmedizin - NuclearMedicine. 50(5). 214–220. 2 indexed citations
3.
Freudenberg, Lutz S., Walter Jentzen, T. Petrich, et al.. (2010). Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisons. European Journal of Nuclear Medicine and Molecular Imaging. 37(12). 2267–2276. 47 indexed citations
4.
Petrich, T., et al.. (2010). In vitro experimental 211At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin. European Journal of Nuclear Medicine and Molecular Imaging. 37(5). 851–861. 18 indexed citations
5.
Wehmeier, Michael, T. Petrich, Korbinian Brand, Ralf Lichtinghagen, & Eric Hesse. (2010). Oncofetal Fibronectin mRNA Is Highly Abundant in the Blood of Patients with Papillary Thyroid Carcinoma and Correlates with High-Serum Thyroid-Stimulating Hormone Levels. Thyroid. 20(6). 607–613. 5 indexed citations
6.
Freudenberg, Lutz S., Cornelia Frömke, T. Petrich, et al.. (2009). Thyroid Remnant Dose: 124I-PET/CT Dosimetric Comparison of rhTSH versus Thyroid Hormone Withholding Before Radioiodine Remnant Ablation in Differentiated Thyroid Cancer. Experimental and Clinical Endocrinology & Diabetes. 118(7). 393–399. 18 indexed citations
7.
Jentzen, Walter, Rainer Görges, T. Petrich, et al.. (2007). 124I-PET dosimetry in advanced differentiated thyroid cancer: Therapeutic impact. Nuklearmedizin - NuclearMedicine. 46(4). 121–128. 71 indexed citations
8.
Hesse, Eric, H. Rosenthal, Florian Laenger, et al.. (2006). Oncogenic Osteomalacia: Exact Tumor Localization by Co-Registration of Positron Emission and Computed Tomography. Journal of Bone and Mineral Research. 22(1). 158–162. 66 indexed citations
9.
10.
Hesse, Eric, Petra B. Musholt, E. Pötter, et al.. (2005). Oncofoetal fibronectin – a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma. British Journal of Cancer. 93(5). 565–570. 17 indexed citations
11.
Mirzayan, M. Javad, et al.. (2005). Detection of multiple extracranial metastases from glioblastoma multiforme by means of whole-body [18F]FDG-PET. European Journal of Nuclear Medicine and Molecular Imaging. 32(7). 853–853. 11 indexed citations
12.
Otto, D., A. R. Boerner, Michael Hofmann, et al.. (2004). Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. European Journal of Nuclear Medicine and Molecular Imaging. 31(10). 60 indexed citations
13.
Petrich, T., A. Börner, D. Otto, Michael Hofmann, & Wolfram H. Knapp. (2002). Influence of rhTSH on [18F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 29(5). 641–647. 109 indexed citations
14.
Petrich, T., et al.. (2002). Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter. European Journal of Nuclear Medicine and Molecular Imaging. 29(7). 842–854. 69 indexed citations
15.
Petrich, T., A. Widjaja, Thomas J. Musholt, et al.. (2001). Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age. European Journal of Nuclear Medicine and Molecular Imaging. 28(2). 203–208. 63 indexed citations
16.
Boerner, A. R., T. Petrich, E. Weckesser, et al.. (2001). Monitoring isotretinoin therapy in thyroid cancer using 18F-FDG PET. European Journal of Nuclear Medicine and Molecular Imaging. 29(2). 231–236. 24 indexed citations
17.
Weckesser, E., B. Soudah, D. Otto, et al.. (2001). Follow-up of thyroid cancer patients using rhTSH -preliminary results. Nuklearmedizin - NuclearMedicine. 40(1). 7–14. 14 indexed citations
18.
Petrich, T., E. Weckesser, B. Soudah, et al.. (2001). [Follow-up of differentiated thyroid cancer patients using rhTSH--preliminary results].. PubMed. 40(1). 7–14. 6 indexed citations
19.
Musholt, Thomas J., et al.. (2000). Familial Papillary Thyroid Carcinoma: Genetics, Criteria for Diagnosis, Clinical Features, and Surgical Treatment. World Journal of Surgery. 24(11). 1409–1417. 71 indexed citations
20.
Widjaja, A., et al.. (1999). Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis.. PubMed. 37(8). 731–3. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Terroir Breakdown of academic impact, for papers by A. Berdelou Breakdown of academic impact, for papers by Rixiang Gong Breakdown of academic impact, for papers by Sheila Lindsay Breakdown of academic impact, for papers by Jingqiang Zhu Breakdown of academic impact, for papers by S. Hescot Breakdown of academic impact, for papers by Francesca Torresan Breakdown of academic impact, for papers by Anthony Glover Breakdown of academic impact, for papers by Helina Somervell Breakdown of academic impact, for papers by Uwe Mäder
Rankless by CCL
2026